Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Transdermal scopolamine and mydriasis].

F Rodor, C Cottin, J Jouglard

    Therapie
    |November 1, 1989
    PubMed
    Summary

    Transdermal scopolamine delivery systems can cause mydriasis, a pupil dilation condition. This side effect was observed in five patients, with some experiencing related eye conditions like glaucoma.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    [Severe oedema after valproate and valpromide].

    Therapie·2002
    Same author

    [Post-marketing surveillance information transmitted via electronic mail in a University Hospital].

    Therapie·2002
    Same author

    [Is nitroxoline an allergen?].

    Therapie·2002
    Same author

    Genetic structure and phylogeography of European catfish (Silurus glanis) populations.

    Molecular ecology·2002
    Same author

    Investigation of fluoroquinolone-induced myalgia using (31)P magnetic resonance spectroscopy and in vitro contracture tests.

    Arthritis and rheumatism·2002
    Same author

    [Amenorrhea and galactorrhea after acute overdose with milnacipran].

    Therapie·2002

    Area of Science:

    • Ophthalmology
    • Pharmacology

    Background:

    • Transdermal scopolamine patches are utilized for various medical conditions, including motion sickness and postoperative nausea.
    • Understanding the potential ocular side effects of transdermal drug delivery is crucial for patient safety.

    Observation:

    • Five cases of mydriasis (abnormal pupil dilation) were reported following the use of transdermal scopolamine.
    • Four of these cases involved anisocoria (unequal pupil size) and narrow-angle glaucoma.

    Findings:

    • Transdermal scopolamine can induce mydriasis as an adverse effect.
    • A high dosage in a pediatric case led to bilateral mydriasis.

    Implications:

    • Ophthalmologists and healthcare providers should be aware of this potential ocular adverse event.
    • Careful patient selection and monitoring are recommended when prescribing transdermal scopolamine, especially in patients with pre-existing glaucoma or risk factors.

    Related Experiment Videos